The MedGuard Pro Series sets a new standard for healthcare-focused sports flooring by incorporating silver-ion infused finishes that eliminate 99.9% of harmful bacteria—including E. coli, Staphylococcus aureus, and MRSA—within 24 hours of contact. This technology prevents the spread of pathogens in high-traffic clinical environments, addressing a critical need for infection control in healthcare settings. Additionally, the flooring meets ISO 10993 biocompatibility standards, ensuring it is safe for patients with sensitive skin, compromised immune systems, or mobility impairments.
Beyond its hygiene benefits, MedGuard Pro delivers clinical-grade performance: a 60% shock absorption rate to support low-impact rehabilitation exercises, a non-slip surface (friction coefficient ≥0.8) optimized for wheelchairs, walkers, and crutches, and a durable 2.8mm maple wear layer that withstands the weight of medical equipment and frequent use. Early adopters include the Mayo Clinic’s Sports Medicine Center in Minnesota and London’s Royal Brompton Hospital, which have installed the flooring in their therapy gyms and patient wellness zones.
“Hygiene and performance are non-negotiable in healthcare sports facilities,” said Dr. James Harper, Limei’s Medical Sector Advisor. “MedGuard Pro bridges these needs, providing a safe, supportive surface that accelerates patient recovery while minimizing infection risk.” The series launched globally in Q3 2027, with applications extending to senior care facilities and specialized physical therapy clinics.